Showing results (281-290 of 354) with videos related to

Sort By:
Pageof 36
The Journal of Urology|March 21, 1998
The use of percent free prostate specific antigen for staging clinically localized prostate cancerJ Pannek, H G Rittenhouse, D W Chan, et al.
The Journal of Urology|April 1, 1996
Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysisA W Partin, S R Criley, E N Subong, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1977
The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancerP C Walsh, J M Greco, C E Tananis, et al.
The Journal of Clinical Investigation|January 1, 1978
Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissuesM Menon, C E Tananis, L L Hicks, et al.
The Journal of Urology|August 1, 1981
Computerized tomography in the diagnosis of retroperitoneal fibrosisR S Feinstein, O M Gatewood, S M Goldman, et al.
The Journal of Urology|October 1, 1989
Evaluation of transrectal ultrasound in the early detection of prostate cancerH B Carter, U M Hamper, S Sheth, et al.
The Journal of Urology|February 1, 1996
Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followupM P Schoenberg, P C Walsh, D R Breazeale, et al.
The Journal of Urology|October 1, 1975
The endocrinology of human chorionic gonadotropin-secreting testicular tumors: new methods in diagnosisJ S Cochran, P C Walsh, J C Porter, et al.
Urology|December 18, 2001
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millenniumA W Partin, L A Mangold, D M Lamm, et al.
JAMA|May 11, 1999
Natural history of progression after PSA elevation following radical prostatectomyC R Pound, A W Partin, M A Eisenberger, et al.
Pageof 36